F51.0 G47.0
Conditions
Interventions
Group 1: Patients with difficulty falling asleep and/or staying asleep are surveyed in a fixed one-time questionnaire.
Sponsors
Johannes Gutenberg-Universität Mainz; Institut für pharmazeutische und biomedizinische Wissenschaften
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: - age = 18 years - intake of a non-prescription sleep aid at the point of questioning - ability to complete the questionnaire independently - ability to understand German adequately, both spoken and written - presence of a written declaration of consent
Exclusion criteria
Exclusion criteria: - inclusion criteria are not accomplished - refusal of declaration of con-sent - insufficient ability to recognize the consequences of participating in the study - first-time application of sleep aid - purchase of compound for another person
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Medication errors: Examination of whether the patient is using the non-prescription sleep aid in accordance with the recommendations underlying the package information leaflet. This refers to contraindications, the recommended duration of use and the indicated dosage. Rare side effects: Examination of whether rare, previously unknown side effects occur when the preparations are used as intended. Other drug-related problems: Examination for side effects as a result of improper use. Special attention is paid here to whether a hangover or rebound effect, a development of tolerance, the occurrence of withdrawal symptoms as well as the development of physical and / or psychological dependency can be observed as a result of the use of sleep aids. | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient knowledge and role of the pharmacist/PTA: Examination of whether the patient is informed about the known side effects, interactions, contraindications and warnings as well as the recommended dosage of his/her sleep aid. Furthermore, it is examined where the patient got his knowledge from and to what extent this affects the self-medication. Individual-related evaluation: Examination of whether differences can be determined due to the various person-related influences (e.g. age, gender, occupation) when evaluating the characteristics to be collected. Pharmacy-related evaluation: Examination of whether differences can be identified in the evaluation of the characteristics to be collected, depending on whether the patient is a customer of a community or a mail-order pharmacy. | — |
Countries
Germany
Contacts
Public ContactVanessa Efinger
Johannes Gutenberg-Universität Mainz; Institut für pharmazeutische und biomedizinische Wissenschaften
Outcome results
None listed